- Home
- QURE vs VCYT Comparison
QURE vs VCYT Comparison
Compare QURE & VCYT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QURE | VCYT |
|---|---|---|
| Founded | 1998 | 2006 |
| Country | Netherlands | United States |
| Employees | 248 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 3.1B |
| IPO Year | 2013 | 2013 |
Fundamental Metrics
Financial Performance| Metric | QURE | VCYT |
|---|---|---|
| Price | $51.05 | $44.04 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 7 |
| Target Price | ★ $45.00 | $44.00 |
| AVG Volume (30 Days) | 1.3M | ★ 1.4M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 29.67 | ★ 164.52 |
| EPS | N/A | ★ 0.66 |
| Revenue | ★ $13,107,000.00 | N/A |
| Revenue This Year | $126.12 | $13.76 |
| Revenue Next Year | $200.43 | $12.35 |
| P/E Ratio | ★ N/A | $62.83 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.73 | $28.25 |
| 52 Week High | $71.50 | $60.91 |
Technical Indicators
Market Signals| Indicator | QURE | VCYT |
|---|---|---|
| Relative Strength Index (RSI) | 64.03 | 36.48 |
| Support Level | $39.50 | $41.03 |
| Resistance Level | $50.47 | $42.10 |
| Average True Range (ATR) | 1.94 | 1.64 |
| MACD | 0.05 | -0.09 |
| Stochastic Oscillator | 82.59 | 25.24 |
Price Performance
Historical ComparisonAbout QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.
About VCYT Veracyte Inc.
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).